CytomX Therapeutics, Inc. (CTMX)
3.425
+0.10
(+3.16%)
USD |
NASDAQ |
Aug 27, 16:00
3.425
0.00 (0.00%)
After-Hours: 20:00
CytomX Therapeutics Price : 3.425 for Aug. 27, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 26, 2026 | 3.35 | 3.38 | 3.285 | 3.32 | 2.216M |
| Aug 25, 2026 | 3.32 | 3.445 | 3.32 | 3.37 | 4.027M |
| Aug 24, 2026 | 3.30 | 3.38 | 3.175 | 3.29 | 3.192M |
| Aug 21, 2026 | 3.31 | 3.415 | 3.27 | 3.28 | 2.895M |
| Aug 20, 2026 | 3.53 | 3.560 | 3.27 | 3.29 | 2.605M |
| Aug 19, 2026 | 3.48 | 3.60 | 3.46 | 3.57 | 4.579M |
| Aug 18, 2026 | 3.41 | 3.435 | 3.30 | 3.39 | 2.457M |
| Aug 17, 2026 | 3.36 | 3.46 | 3.34 | 3.45 | 2.365M |
| Aug 14, 2026 | 3.34 | 3.385 | 3.28 | 3.36 | 1.433M |
| Aug 13, 2026 | 3.50 | 3.50 | 3.34 | 3.35 | 1.809M |
| Aug 12, 2026 | 3.48 | 3.535 | 3.415 | 3.49 | 2.519M |
| Aug 11, 2026 | 3.42 | 3.50 | 3.37 | 3.45 | 1.699M |
| Aug 10, 2026 | 3.45 | 3.495 | 3.385 | 3.44 | 1.796M |
| Aug 07, 2026 | 3.32 | 3.55 | 3.30 | 3.46 | 2.462M |
| Aug 06, 2026 | 3.31 | 3.40 | 3.29 | 3.37 | 1.937M |
| Aug 05, 2026 | 3.30 | 3.375 | 3.27 | 3.35 | 2.031M |
| Aug 04, 2026 | 3.23 | 3.33 | 3.215 | 3.32 | 2.437M |
| Aug 03, 2026 | 3.09 | 3.18 | 3.01 | 3.17 | 3.797M |
| Jul 31, 2026 | 3.26 | 3.281 | 3.10 | 3.10 | 3.502M |
| Jul 30, 2026 | 3.18 | 3.29 | 3.155 | 3.28 | 1.758M |
| Jul 29, 2026 | 3.21 | 3.35 | 3.15 | 3.17 | 1.365M |
| Jul 28, 2026 | 3.26 | 3.274 | 3.13 | 3.22 | 2.008M |
| Jul 27, 2026 | 3.25 | 3.43 | 3.25 | 3.25 | 2.502M |
| Jul 24, 2026 | 3.34 | 3.38 | 3.20 | 3.24 | 1.520M |
| Jul 23, 2026 | 3.31 | 3.405 | 3.275 | 3.33 | 1.381M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Regeneron Pharmaceuticals, Inc. | 807.59 |
| Ocugen, Inc. | 1.375 |
| iBio, Inc. | 1.40 |
| Cardiff Oncology, Inc. | 0.989 |
| Capricor Therapeutics, Inc. | 10.07 |
Price Related Metrics
| PS Ratio | 34.22 |
| Price to Book Value | 2.471 |
| Earnings Yield | -13.34% |
| Market Cap | 746.31M |